These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antibody studies of factor VIII inhibitor in a case with Waldenström's macroglobulinemia. Endo T; Yatomi Y; Amemiya N; Mizoe A; Iino M; Ozawa H; Hosogaya S; Ozaki Y Am J Hematol; 2000 Mar; 63(3):145-8. PubMed ID: 10679805 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of blood platelet aggregation by serum IgM macroglobulin. Preliminary report. Farbiszewski R; Worowski K Haematologia (Budap); 1970; 4(1):75-7. PubMed ID: 5001250 [No Abstract] [Full Text] [Related]
7. Acquired inhibitors of coagulation in nonhemophiliac children. Brodeur GM; O'Neill PJ; Willimas JA J Pediatr; 1980 Mar; 96(3 Pt 1):439-41. PubMed ID: 7359239 [No Abstract] [Full Text] [Related]
8. Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis. Meier C; Roberts K; Steck A; Hess C; Miloni E; Tschopp L Acta Neuropathol; 1984; 64(4):297-307. PubMed ID: 6095580 [TBL] [Abstract][Full Text] [Related]
9. A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy. Brody JI; Haidar ME; Rossman RE N Engl J Med; 1979 Feb; 300(8):408-10. PubMed ID: 104178 [No Abstract] [Full Text] [Related]
11. [The role of the weak factor VIII inhibitors]. Mayer G; Noel G; Waitz R Acta Haematol; 1969; 42(1):27-41. PubMed ID: 4982619 [No Abstract] [Full Text] [Related]
12. Disulfide bonds of human IgM: differential sensitivity to reductive cleavage. Kownatzki E Scand J Immunol; 1973; 2(4):433-7. PubMed ID: 4203676 [No Abstract] [Full Text] [Related]
13. Macroglobulinemia of Waldenström diagnosis and management. Messmore HL; Fareed J; Silberman S; Gawlik GM; Bermes EW Ann Clin Lab Sci; 1978; 8(4):310-7. PubMed ID: 99073 [No Abstract] [Full Text] [Related]
14. Isoantibodies to human IgM: serologic and immunochemical investigations. Leikola J; Fudenberg HH; Vyas GN; Perkins HA J Immunol; 1971 May; 106(5):1147-53. PubMed ID: 4995748 [No Abstract] [Full Text] [Related]
15. [Waldenström's macroglobulinemia]. Mongin M Sem Hop; 1969 Jun; 45(30):2104-6. PubMed ID: 4309108 [No Abstract] [Full Text] [Related]
16. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII. Pechet L; Snyder LM; Chesney C; Colman RW Thromb Diath Haemorrh; 1974 Sep; 32(1):90-104. PubMed ID: 4548947 [TBL] [Abstract][Full Text] [Related]
17. [The hemostatic mechanism in presence of pathological macroglobulins. Findings in a case of macroglobulinemia associated with neoplasms of the bladder]. Pratesi G; Fremiotti A; Masi M Recenti Prog Med; 1967 Mar; 42(3):23-36. PubMed ID: 4973726 [No Abstract] [Full Text] [Related]
18. Inhibition of clot retraction by previous in vitro platelet aggregation. De Gaetano G; Donati MB; Vermylen J; Verstraete M Thromb Diath Haemorrh; 1971 Dec; 26(3):449-54. PubMed ID: 5144960 [No Abstract] [Full Text] [Related]
19. Antigenic heterogeneity of reduced and alkylated subunits of human monoclonal macroglobulins. Dominguez CJ; Caggiano V; Kochwa S; Wasserman LR J Immunol; 1968 Dec; 101(6):1159-67. PubMed ID: 4972621 [No Abstract] [Full Text] [Related]
20. Acquired factor VIII inhibitor associated with lung abscess. Ganly PS; Isaacs JD; Laffan MA; Haslett C; Hows JM Br Med J (Clin Res Ed); 1987 Oct; 295(6602):811. PubMed ID: 3119053 [No Abstract] [Full Text] [Related] [Next] [New Search]